Shivani Sood, MD | |
79 Wawecus St, Suite 101, Norwich, CT 06360-2160 | |
(860) 886-2655 | |
(860) 887-9003 |
Full Name | Shivani Sood |
---|---|
Gender | Female |
Speciality | Gastroenterology |
Experience | 22 Years |
Location | 79 Wawecus St, Norwich, Connecticut |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1356500532 | NPI | - | NPPES |
P00687675 | Other | MEDICARE RAILROAD PTAN | |
010046556CT01 | Other | CT | ANTHEM BLUE CROSS BLUE SHIELD OF CT |
046556 | Other | CT | CONNECTICARE, INC |
9643135 | Other | AETNA | |
P3929070 | Other | OXFORD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | 046556 (Connecticut) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
William W Backus Hospital | Norwich, CT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
United Community And Family Services, Inc | 9032012497 | 34 |
Connecticut Gi Pc | 9830110758 | 185 |
News Archive
A team led by researchers of the Institute of Biomedicine of the University of Barcelona and the Research Institute of the Hospital de la Santa Creu i Sant Paushows for the first time, the three-dimensional structure of the homodimeric androgen receptor ligand-binding domain, a structure that eluded researchers for years.
Results from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages 6-11 with uncontrolled moderate-to-severe asthma, compared to placebo, according to research presented at the ATS 2021 International Conference. VOYAGE (NCT02948959) is a recently completed randomized, placebo-controlled double-blind multicenter phase 3 clinical trial, that took place in a number of countries.
Instem, a leading provider of early drug development software solutions, announced today the establishment of an office in Shanghai to provide local customer support, service delivery, client management, development and sales support to the Chinese pharmaceutical and wider life sciences R&D market.
GeneTex, Inc., a leading manufacturer of antibodies, has announced that they will be launching a new antibody against HIF1a (hypoxia-inducible factor 1alpha).
› Verified 9 days ago
Entity Name | United Community And Family Services, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467482539 PECOS PAC ID: 9032012497 Enrollment ID: O20040202000086 |
News Archive
A team led by researchers of the Institute of Biomedicine of the University of Barcelona and the Research Institute of the Hospital de la Santa Creu i Sant Paushows for the first time, the three-dimensional structure of the homodimeric androgen receptor ligand-binding domain, a structure that eluded researchers for years.
Results from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages 6-11 with uncontrolled moderate-to-severe asthma, compared to placebo, according to research presented at the ATS 2021 International Conference. VOYAGE (NCT02948959) is a recently completed randomized, placebo-controlled double-blind multicenter phase 3 clinical trial, that took place in a number of countries.
Instem, a leading provider of early drug development software solutions, announced today the establishment of an office in Shanghai to provide local customer support, service delivery, client management, development and sales support to the Chinese pharmaceutical and wider life sciences R&D market.
GeneTex, Inc., a leading manufacturer of antibodies, has announced that they will be launching a new antibody against HIF1a (hypoxia-inducible factor 1alpha).
› Verified 9 days ago
Entity Name | Connecticut Gi Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023124625 PECOS PAC ID: 9830110758 Enrollment ID: O20070112000011 |
News Archive
A team led by researchers of the Institute of Biomedicine of the University of Barcelona and the Research Institute of the Hospital de la Santa Creu i Sant Paushows for the first time, the three-dimensional structure of the homodimeric androgen receptor ligand-binding domain, a structure that eluded researchers for years.
Results from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages 6-11 with uncontrolled moderate-to-severe asthma, compared to placebo, according to research presented at the ATS 2021 International Conference. VOYAGE (NCT02948959) is a recently completed randomized, placebo-controlled double-blind multicenter phase 3 clinical trial, that took place in a number of countries.
Instem, a leading provider of early drug development software solutions, announced today the establishment of an office in Shanghai to provide local customer support, service delivery, client management, development and sales support to the Chinese pharmaceutical and wider life sciences R&D market.
GeneTex, Inc., a leading manufacturer of antibodies, has announced that they will be launching a new antibody against HIF1a (hypoxia-inducible factor 1alpha).
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Shivani Sood, MD 79 Wawecus St, Suite 101, Norwich, CT 06360-2160 Ph: (860) 886-2655 | Shivani Sood, MD 79 Wawecus St, Suite 101, Norwich, CT 06360-2160 Ph: (860) 886-2655 |
News Archive
A team led by researchers of the Institute of Biomedicine of the University of Barcelona and the Research Institute of the Hospital de la Santa Creu i Sant Paushows for the first time, the three-dimensional structure of the homodimeric androgen receptor ligand-binding domain, a structure that eluded researchers for years.
Results from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages 6-11 with uncontrolled moderate-to-severe asthma, compared to placebo, according to research presented at the ATS 2021 International Conference. VOYAGE (NCT02948959) is a recently completed randomized, placebo-controlled double-blind multicenter phase 3 clinical trial, that took place in a number of countries.
Instem, a leading provider of early drug development software solutions, announced today the establishment of an office in Shanghai to provide local customer support, service delivery, client management, development and sales support to the Chinese pharmaceutical and wider life sciences R&D market.
GeneTex, Inc., a leading manufacturer of antibodies, has announced that they will be launching a new antibody against HIF1a (hypoxia-inducible factor 1alpha).
› Verified 9 days ago
Dr. Ting Li, M.D., PH.D., F.A.C.C Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 112 Lafayette St, Norwich, CT 06360 Phone: 860-572-5400 Fax: 860-245-0001 | |
Ankit Gupta, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 330 Washington St Ste 430, Norwich, CT 06360 Phone: 860-886-1862 Fax: 860-886-2046 | |
Dr. Mohammed A Qureshi, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 326 Washington St, Norwich, CT 06360 Phone: 860-889-8331 | |
Kandhasamy Jagathambal, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 330 Washington St, Ste 220 Eastern Ct Hematology & Oncology, Norwich, CT 06360 Phone: 860-886-8362 Fax: 860-886-9262 | |
Dr. Paras Satish Bhatt, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 164 Ontrobando Ave, Norwich, CT 06360 Phone: 860-889-9180 | |
Maria Sabsay Goral, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 326 Washington St, The William W.backus Hospital, Norwich, CT 06360 Phone: 860-885-6420 Fax: 860-892-6984 | |
Joselito Endaya, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1 Towne Park Plz, Norwich, CT 06360 Phone: 860-887-0010 Fax: 860-887-0178 |